Antiphospholipid antibodies and thrombosis in severe COVID-19 pneumonia: A difficult relationship
- PMID: 32788115
- PMCID: PMC7319616
- DOI: 10.1016/j.thromres.2020.06.040
Antiphospholipid antibodies and thrombosis in severe COVID-19 pneumonia: A difficult relationship
Comment on
-
Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism.Thromb Res. 2020 Aug;192:113-115. doi: 10.1016/j.thromres.2020.05.017. Epub 2020 May 15. Thromb Res. 2020. PMID: 32425261 Free PMC article.
References
-
- Galeano-Valle F., Oblitas C.M., Ferreiro-Mazon M.M., Alonso-Munoz J., del Toro-Cervera, Demelo-Rodriguez P. Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism. Thromb. Res. Aug 2020;192:113–115. doi: 10.1016/j.thromres.2020.05.017. - DOI - PMC - PubMed
-
- Devreese K.M.J., Ortel T.L., Pengo V., de Laat B for the Subcommittee on Lupus Anticoagulant/Antiphospholipid antibodies Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH. J. Thromb. Haemost. 2018;16:809–813. - PubMed
-
- Pengo V., Testa S., Martinelli I., Ghirarduzzi A., Legnani C., Gresele P. Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulant. Thromb. Res. 2015;135(1):46–49. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical